FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

407889001: Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment (clinical drug)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
3693997012 Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT United Kingdom drug extension module
107826901000001119 Tacrolimus 0.03% ointment en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Is a Product containing tacrolimus in topical dosage form false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has active ingredient Tacrolimus false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has active ingredient Skin agent false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Is a Product containing tacrolimus in topical dosage form false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has active ingredient Tacrolimus false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has active ingredient Skin agent false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has precise active ingredient Tacrolimus monohydrate true Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has concentration strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has concentration strength numerator value 300 false Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has basis of strength substance Tacrolimus true Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Is a Product containing only tacrolimus in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has active ingredient Tacrolimus false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Is a Tacrolimus true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has active ingredient Tacrolimus monohydrate false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tacrolimus true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has specific active ingredient Tacrolimus monohydrate false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has specific active ingredient Tacrolimus monohydrate true Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has basis of strength substance Tacrolimus false Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Protopic 0.03% ointment Is a False Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Protopic 0.03% ointment (Fujisawa Ltd) Is a True Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.03% ointment 60 gram Is pack of False Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.03% ointment 30 gram Is pack of False Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Protopic 0.03% ointment (PI) (Waymade Ltd) Is a True Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Protopic 0.03% ointment (Sigma Pharmaceuticals Plc) Is a True Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.03% ointment 60 gram Has VMP True Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.03% ointment 30 gram Has VMP True Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start